Novartis
Novartis Q3 operating income up 6% on new drug sales
Third-quarter operating income, adjusted for special items, rose to US$5.46 billion
Novartis agrees to buy Avidity in US$12 billion biotech deal
The full deal is expected to close in the first half of 2026, subject to the completion of the separation
Novartis Singapore steps up in the race to net zero
As part of its plans, it has implemented on-site solar panels, is purchasing all its electricity from renewable source, and exploring green heat technologies
Novartis to buy US biotech Tourmaline Bio for US$1.4 billion
Novartis is on the hunt for acquisitions that could boost its sales beyond 2025
Novartis pledges US$23 billion US investment as tariffs loom
Trump has repeatedly said he intends to impose tariffs on pharmaceuticals, citing the industry’s reliance on manufacturing sites around the world to supply the US market
Novartis to acquire Anthos for up to US$3.1 billion
The transaction will cost Novartis US$925 million upfront with potential additional payment of up to US$2.15 billion
Novartis to buy radiology specialist Mariana Oncology for US$1 billion
Mariana Oncology is a preclinical-stage biotechnology company focused on developing novel radioligand therapies to treat cancers
Novartis invests US$256 million to expand Singapore plant
SWISS biopharma giant Novartis has invested US$256 million to expand its biopharmaceutical manufacturing plant in Singapore. The expanded site will focus on manufacturing therapeutic antibody drugs.
Novartis to acquire cancer-focused MorphoSys for 2.7 billion euros
DRUGMAKER Novartis said it will acquire MorphoSys, a developer of cancer treatments, for 2.7 billion euros (S$3.9 billion), adding a promising rare bone-marrow cancer treatment candidate to its portfo...
Novartis signs gene therapy deal with Voyager for US$100 million upfront
Voyager Therapeutics said on Tuesday (Jan 2) Swiss-based drugmaker Novartis would pay US$100 million upfront as part of a licensing deal to develop gene therapy candidates for genetic disorders.